Back to
RENAISSANCE TECHNOLOGIES LLC
QNCX
Showing 7 of 20 quarters
Position history for
RENAISSANCE TECHNOLOGIES LLC's holdings in QUINCE THERAPEUTICS INC
No. Renaissance Technologies exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 538,100 shares worth $1.8M. Renaissance Technologies first reported QNCX in Q1 2020 and held it in 18 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$405,624
Total Shares Change
-522,576
Quarter-by-Quarter History